We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

27 hedge funds and large institutions have $23M invested in Cumberland Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% more ownership

Funds ownership: 29.16% → 29.38% (+0.22%)

4% less funds holding

Funds holding: 28 → 27 (-1)

14% less capital invested

Capital invested by funds: $26.6M → $23M (-$3.61M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
5
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$274K
2
SCM
Stonepine Capital Management
Oregon
+$189K
3
UBS Group
UBS Group
Switzerland
+$8.16K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.22K
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.06K

Top Sellers

Rank Fund Capital Flow
1
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
-$528K
2
PPA
Parametric Portfolio Associates
Washington
-$80K
3
FGAM
Financial Gravity Asset Management
Texas
-$21.1K
4
Deutsche Bank
Deutsche Bank
Germany
-$18.3K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$16.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$5.2M +$274K +51,901 +5%
SCM
2
Stonepine Capital Management
Oregon
$4.62M +$189K +35,721 +4%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$4.43M +$1.22K +231 +0%
Renaissance Technologies
4
Renaissance Technologies
New York
$2.42M +$1.06K +200 +0%
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.02M +$523 +99 +0%
BlackRock
6
BlackRock
New York
$1.71M -$3.15K -597 -0.2%
BCM
7
Bridgeway Capital Management
Texas
$942K – – –
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$506K -$16.3K -3,088 -3%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$277K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$250K – – –
Northern Trust
11
Northern Trust
Illinois
$128K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$104K – – –
UCFA
13
United Capital Financial Advisors
Texas
$84K – – –
Morgan Stanley
14
Morgan Stanley
New York
$78K -$3.61K -683 -4%
B
15
Bailard
California
$61K – – –
Cambridge Investment Research Advisors
16
Cambridge Investment Research Advisors
Iowa
$52K – – –
Russell Investments Group
17
Russell Investments Group
United Kingdom
$24K – – –
ACM
18
Anfield Capital Management
California
$23K +$23.9K +4,530 New
OC
19
Oakworth Capital
Alabama
$16K – – –
FGAM
20
Financial Gravity Asset Management
Texas
$10K -$21.1K -4,000 -67%
UBS Group
21
UBS Group
Switzerland
$8K +$8.16K +1,546 New
Deutsche Bank
22
Deutsche Bank
Germany
$5K -$18.3K -3,467 -74%
PAM
23
Panagora Asset Management
Massachusetts
$3K – – –
Bank of America
24
Bank of America
North Carolina
$1K -$1.67K -316 -67%
TRCT
25
Tower Research Capital (TRC)
New York
$1K +$570 +108 New
1
2

CPIX Hedge Fund Activity: Q4 2019 in Review

27 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2019, worth a combined $23M — down 14% from $26.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CPIX and 3 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.

The largest buyer was Ariel Investments, adding an estimated $274K. The largest seller was Dalton, Greiner, Hartman, Maher & Co, exiting entirely with an estimated $528K sold.

  • 27 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2019, down from 28 in Q3 2019.
  • Funds reported $23M of Cumberland Pharmaceuticals stock for Q4 2019, down 14% quarter-over-quarter.
  • 3 funds opened new Cumberland Pharmaceuticals positions in Q4 2019 and 4 closed out, a net change of -1 holder.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2019 was Ariel Investments, an estimated $274K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2019 was Dalton, Greiner, Hartman, Maher & Co, an estimated $528K sold.

Based on aggregated 13F filings for Q4 2019.